Arshad Khanani, MD, offers insight on the safety measures he and staff have implemented at the Sierra Eye Associates multi-specialty practice in Reno, Nevada, to ensure proper caution for the
Roberto Pinelli, MD, CEO and founder of the Switzerland Eye Research Institute, shares how operations at the facility have adapted to the growing coronavirus pandemic spreading across the globe
Paul Sidoti, MD, site chair of the Department of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai System Chief, offers insight on changes — both onsite and offsite — that have been implemen
Artificial intelligence (AI) is the subject of numerous articles that tout how well machines function better than human ophthalmologists, but why is this happening?
Carl Awh, MD, explains offers insight on the changes his practice (Tennessee Retina in Nashville, Tennessee), has implemented for the sake of staff/patients' health, as well as the safety precaution
Rishi Singh, MD, offers an update on the precautions eye care professionals and staff are taking at the Cole Eye Institute (Cleveland Clinic) to ensure the health and safety of both patients and physicians during the coronavirus pandemic.
Special to Ophthalmology Times®
Diabetic macular edema (DME) is a significant cause of vision loss in patients with diabetes.
IRIS Registry study: Overall anti-VEGF injection intervals for wet AMD similar at 1, 2 years of treatment
Editor’s Note: This article was adapted from Dr.
Awareness of the development of age-related macular degeneration (AMD) has been increasing slowly with the recognition of the advancing age of the population.
Nearly 50% of eyes with wet age-related macular degeneration (AMD) have stable or improved vision after long-term, 8-year pro re nata (PRN) treatment with ranibizumab, according to a group of U.K. clinicians.